Sales & Marketing Views & Analysis

Views & Analysis

Tackling adherence is “only sustainable path to profit”

Every year, pharmaceutical companies lose an eye-watering $637bn through medication non-adherence – so why isn’t the industry taking this money-eating bull by the horns?

Views & Analysis

How to keep innovating when roadblocks stand in your way

With its position as one of the top

Sales & Marketing

Acting on the moments that matter to build a brand

All too often pharmaceutical marketing orthodoxy says to focus on just one area – a product’s launch, in the belief that this is the only area that can determine success.

Views & Analysis

Pfizer’s Pol Vandenbroucke on the changing industry

Ahead of the 2019 eyeforpharma Barcelona conference, we asked speaker Pol Vandenbroucke – chief medical officer of the Hospital Business Unit at Pfizer – for his view

Views & Analysis

JP Morgan Healthcare: where science, tech and finance collid...

Welcome to 2019! Hopefully by now you’re managing to ease yourself back into things, no doubt with good intentions for the year ahead.

Sales & Marketing

Doctor holding hands for comforting and care patient

Designing behavioural science-based patient support programm...

We all exhibit behaviours that are, at times, irrational, and this presents a major challenge for pharmaceutical companies that are developing patient support programmes.

Tackling adherence is “only sustainable path to profit”

How to keep innovating when roadblocks stand in your way

Acting on the moments that matter to build a brand

Pfizer’s Pol Vandenbroucke on the changing industry

JP Morgan Healthcare: where science, tech and finance collid...

Designing behavioural science-based patient support programm...

CMS aims for broader GLP-1 access via federal programmes

How to meet your physicians where they are online

Views & Analysis

Editor's Picks